Lindstrom: Future of cataract surgery in US includes bilateral, in-office procedures
KIAWAH ISLAND, S.C. — Depending on a number of different scenarios, the future of cataract surgery in the U.S. will include in-office immediate sequential bilateral cataract surgery.
In his keynote lecture at Kiawah Eye, Richard L. Lindstrom, MD, said that a number of innovations and changes, such as greater implantation of the Light Adjustable Lens (RxSight) and changing reimbursement, will lead to widespread adoption of in-office ISBCS.
An aging, more active, growing population of people seeking cataract surgery will lead to these and other innovations, according to Lindstrom. He projected by 2030 the demand for 6 million cataract surgeries a year compared with 4 million in 2019, being performed by about 10,000 ophthalmologists, roughly the same number as in 2019.
He sees a split of 60% monofocal IOL implantations to 40% premium IOLs.
“The top-of-the-line premium IOL in 2030 will be an adjustable, accommodating IOL with reduced PCO in an automated, single-use, preloaded injector,” Lindstrom said.
He also projected that phacoemulsification will evolve into phacoaspiration due to technologies such as the CataPulse (Med-Logics), miLOOP (Zeiss) and miPORT (Zeiss), obviating the need for phacoemulsification energy delivered to the eye.
Collapse
Lindstrom RL. Thoughts on the future of cataract surgery. Presented at: Kiawah Eye; June 3-5, 2021; Kiawah Island, S.C.
Read more about